Unilateral primary aldosteronism with spontaneous remission after long-term spironolactone therapy

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 4, 2012, Pages 1109-1113

  Yoneda, Takashi ^a   Demura, Masashi ^a   Takata, Hiroyuki ^a   Kometani, Mitsuhiro ^a   Karashima, Shigehiro ^a   Yamagishi, Masakazu ^a   Takeda, Yoshiyu ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CAPTOPRIL; ENALAPRIL; FUROSEMIDE; NIFEDIPINE; POTASSIUM; SPIRONOLACTONE;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; HEART VENTRICLE HYPERTROPHY; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; HYPOKALEMIA; LONG TERM CARE; MALE; METABOLIC ALKALOSIS; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PROVOCATION TEST; REMISSION; TREATMENT RESPONSE;

ADRENAL GLAND NEOPLASMS; ADULT; ALDOSTERONE; ALDOSTERONE ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; CARDIOMEGALY; ENALAPRIL; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; MALE; RECEPTORS, MINERALOCORTICOID; REMISSION INDUCTION; SPIRONOLACTONE; TUMOR BURDEN;

EID: 84859546091     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2563     Document Type: Article

References (24)

1. Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T 2004 Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 27:193-202 (Pubitemid 38489081)
2. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young Jr WF, Montori VM 2008 Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93:3266-3281
3. Armanini D, Scaroni C, Mattarello MJ, Fiore C, Albiger N, Sartorato P 2005 Idiopathic primary hyperaldosteronism: normalization of plasma aldosterone after one month withdrawal of long-term therapy with aldosterone-receptor antagonist potassium canrenoate. J Endocrinol Invest 28:236-240 (Pubitemid 43162771)
4. Armanini D, Fiore C, Pellati D 2007 Spontaneous resolution of idiopathic aldosteronism after long-term treatment with potassium canrenoate. Hypertension 50:e69-e70 (Pubitemid 47442748)
5. Fischer E, Beuschlein F, Degenhart C, Jung P, Bidlingmaier M, Reincke M 29 September 2011 Spontaneous remission of idiopathic aldosteronism after long-term treatment with spironolactone: results from the German Conn's Registry. Clin Endocrinol (Oxf) 10.1111/j.1365-2265.2011.04243.x
6. Gordon RD, Stowasser M, Klemm SA, Tunny TJ 1995 Primary aldosteronism - some genetic, morphological, and biochemical aspects of subtypes. Steroids 60:35-41
7. Menard RH, Loriaux DL, Bartter FC, Gillette JR 1978 The effect of the administration of spironolactone on the concentration of plasma testosterone, estradiol and cortisol in male dogs. Steroids 31:771-782 (Pubitemid 9119854)
8. Rourke KA, Colby HD 1990 Spironolactone inhibition of cortisol production by guinea pig adrenocortical cells. Horm Metab Res 22:573-575
9. Rourke KA, Bergstrom JM, Larson IW, Colby HD 1991 Mechanism of action of spironolactone on cortisol production by guinea pig adrenocortical cells. Mol Cell Endocrinol 81:127-134
10. Kossor DC, Kominami S, Takemori S, Colby HD 1991 Role of the steroid 17α-hydroxylase in spironolactone-mediated destruction of adrenal cytochrome P-450. Mol Pharmacol 40:321-325
11. Kossor DC, Colby HD 1992 Dose-dependent actions of spironolactone on the inner and outer zones of the guinea pig adrenal cortex. Pharmacology 45:27-33
12. Ye P, Yamashita T, Pollock DM, Sasano H, Rainey WE 2009 Contrasting effects of eplerenone and spironolactone on adrenal cell steroidogenesis. Horm Metab Res 41:35-39
13. Demura M, Wang F, Yoneda T, Karashima S, Mori S, Oe M, Kometani M, Sawamura T, Cheng Y, Maeda Y, Namiki M, Ino H, Fujino N, Uchiyama K, Tsubokawa T, Yamagishi M, Nakamura Y, Ono K, Sasano H, Demura Y, Takeda Y 2011 Multiple noncoding exons 1 of nuclear receptors NR4A family (nerve growth factor-induced clone B, Nur-related factor 1 and neuron-derived orphan receptor 1) and NR5A1 (steroidogenic factor 1) in human cardiovascular and adrenal tissues. J Hypertens 29:1185-1195
14. Aiba M, Suzuki H, Kageyama K, Murai M, Tazaki H, Abe O, Saruta T 1981 Spironolactone bodies in aldosteronomas and in the attached adrenals. Enzyme histochemical study of 19 cases of primary aldosteronism and a case of aldosteronism due to bilateral diffuse hyperplasia of the zona glomerulosa. Am J Pathol 103:404-410 (Pubitemid 11064743)
15. Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, Tamura N, Tanabe A 2011 Guidelines for the diagnosis and treatment of primary aldosteronism - the Japan Endocrine Society 2009. Task Force Committee on Primary Aldosteronism, The Japan Endocrine Society. Endocr J 58:711-721
16. Hirohara D, Nomura K, Okamoto T, Ujihara M, Takano K 2001 Performance of the basal aldosterone to renin ratio and of the renin stimulation test by furosemide and upright posture in screening for aldosterone-producing adenoma in low renin hypertensives. J Clin Endocrinol Metab 86:4292-4298 (Pubitemid 32848549)
17. Bernini G, Bacca A, Carli V, Carrara D, Materazzi G, Berti P, Miccoli P, Pisano R, Tantardini V, Bernini M, Taddei S 21 March 2011 Cardiovascular changes in patients with primary aldosteronism after surgical or medical treatment. J Endocrinol Invest 10.3275/7611
18. Giacchetti G, Ronconi V, Turchi F, Agostinelli L, Mantero F, Rilli S, Boscaro M 2007 Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. J Hypertens 25:177-186 (Pubitemid 44885680)
19. Rossi GP, Sacchetto A, Pavan E, Palatini P, Graniero GR, Canali C, Pessina AC 1997 Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma. Circulation 95:1471-1478 (Pubitemid 27142805)
20. Ghose RP, Hall PM, Bravo EL 1999 Medical management of aldosterone producing adenomas. Ann Intern Med 131:105-108 (Pubitemid 29340561)
21. Sywak M, Pasieka JL 2002 Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism. Br J Surg 89:1587-1593 (Pubitemid 35404330)
22. Reimel B, Zanocco K, Russo MJ, Zarnegar R, Clark OH, Allendorf JD, Chabot JA, Duh QY, Lee JA, Sturgeon C 2010 The management of aldosterone-producing adrenal adenomas - does adrenalectomy increase costs? Surgery 148:1178-1185
23. Sechi LA, Colussi G, Di Fabio A, Catena C 2010 Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment. Am J Hypertens 23:1253-1260
24. Catena C, Colussi G, Lapenna R, Nadalini E, Chiuch A, Gianfagna P, Sechi LA 2007 Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension 50:911-918 (Pubitemid 350287534)